Maternal and neonatal outcomes after antepartum treatment of influenza with antiviral medications.
about
Treatment of infections during pregnancy: Progress and challengesLow clinical burden of 2009 pandemic influenza A (H1N1) infection during pregnancy on the island of La RéunionImpact on pregnancies in south Brazil from the influenza A (H1N1) pandemic: cohort study.Pregnancy outcome following maternal use of zanamivir or oseltamivir during the 2009 influenza A/H1N1 pandemic: a national prospective surveillance study.The safety of oseltamivir in pregnancy: an updated review of post-marketing data.Risk management of seasonal influenza during pregnancy: current perspectives.Influenza virus infection in pregnancy: a review.Influenza and its treatment during pregnancy: A review.French experience of 2009 A/H1N1v influenza in pregnant women.Safety profile of oseltamivir during the 2009 influenza pandemic.Clinical characteristics of pregnant women with influenza-like illness during the 2009 H1N1 pandemic and use of a standardized management algorithm.Optimizing knowledge of antiviral medications for prophylaxis and treatment of influenza during pregnancy.Influenza-like illness in hospitalized pregnant and postpartum women during the 2009-2010 H1N1 pandemic.Oseltamivir in seasonal, pandemic, and avian influenza: a comprehensive review of 10-years clinical experience.Review of the pandemic (H1N1) 2009 among pregnant Japanese women.Influenza in pregnancy.Clinical use of approved influenza antivirals: therapy and prophylaxis.Neuraminidase inhibitors during pregnancy and risk of adverse neonatal outcomes and congenital malformations: population based European register study.Pregnancy outcomes of women exposed to laninamivir during pregnancy.Human teratogens update 2011: can we ensure safety during pregnancy?[Severe forms of influenza A (H1N1) 2009 in pregnant women: experience of the University Hospital of Fez, Morocco and literature review]Oseltamivir for influenza in pregnancy.Oseltamivir for the treatment of H1N1 influenza during pregnancy.Volkmann ischemic contracture in a newborn.A Review of Antiviral and Antifungal Use and Safety during Pregnancy.Safety of oseltamivir during pregnancy: a comparative study using the EFEMERIS database.Birth outcomes among women exposed to neuraminidase inhibitors during pregnancy.
P2860
Q29994667-58FF895A-FC6C-48B7-85C6-EC6133175F4DQ30227122-2CBB56C3-601F-45E4-8DF1-C2DE34CAC9AAQ30359307-34EC0ABA-14FF-49AA-BBEE-454A66EBB88FQ30359847-B87BE5FE-49B6-4E11-8BB1-381F0C35166EQ30364365-F33ABAEC-B1B4-4053-9EFC-FF72A675B14CQ30365596-BFD4465C-2951-44A4-9292-9C3E29976D5AQ30374989-9486F0D9-A371-4851-AC35-DE9FBCAED780Q30384118-972D2A8A-FA71-4496-A68F-3D2C1F0639ACQ30395018-3FBF3024-F666-4639-AAFE-D796E5E9DE80Q30401279-FA1C029A-D9D8-45AE-B0C3-E42274AC2052Q30402030-129E5F0B-7359-4340-9178-DD37B18222D5Q30406272-385F42A1-6A58-4612-9034-DE66CE7D5906Q30406291-B53183EE-9E6C-4EF6-B44E-66FEA5557C53Q30409023-E2F63613-FEDE-4C6D-9A88-F9C0FF5613FCQ30415160-8659D664-BDB6-4262-AC38-A60DB85995BFQ30423910-4AF2C540-3412-478A-8A49-85B5B2CA182FQ30425343-7BCE00FF-CD69-4A31-BF9A-7420B7D5F2A8Q33647254-02AF3644-992A-4EDA-B1F3-6EE9EF367902Q34693369-620ED8F4-AC41-49E6-9F53-D7960AB315D8Q35815011-841CFE8E-2FCC-44F1-B8B7-78558F2907C9Q35885433-AEC0EBBC-2EA3-4E9B-B3EF-29B2ACEA0F45Q38256591-A5D7E70B-35DE-452A-9035-FFC0974F0510Q38537284-F5562C13-E8EC-4DC6-B5A7-4D140BC82062Q38612194-D860543D-79AF-4982-826A-D89D090DF395Q38823841-4AEA6971-76EF-42D9-A8DA-27F24AF9C0ECQ42229134-8AF2E3F2-7EF1-4CB9-A7DA-9593CA6BC7E3Q47837392-4050FB9C-D04F-4A5F-996F-12AF6EFBD508
P2860
Maternal and neonatal outcomes after antepartum treatment of influenza with antiviral medications.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Maternal and neonatal outcomes ...... za with antiviral medications.
@en
Maternal and neonatal outcomes ...... za with antiviral medications.
@nl
type
label
Maternal and neonatal outcomes ...... za with antiviral medications.
@en
Maternal and neonatal outcomes ...... za with antiviral medications.
@nl
prefLabel
Maternal and neonatal outcomes ...... za with antiviral medications.
@en
Maternal and neonatal outcomes ...... za with antiviral medications.
@nl
P2093
P1476
Maternal and neonatal outcomes ...... za with antiviral medications.
@en
P2093
Donald D McIntire
George D Wendel
Laura G Greer
Scott W Roberts
Vanessa L Rogers
P304
P356
10.1097/AOG.0B013E3181D44752
P407
P577
2010-04-01T00:00:00Z